Developer docs
API playgroundTry for free, no card

Search company profiles

Myoderm

Full company profile

uuid002bmv4

Namestring
Myoderm
Legal namestring
Myonex, LLC
Websiteurl
myonex.com
Company typeenum
Private
Founded yearint
1931
Descriptiontext

Myoderm, operating globally as Myonex, is a family-owned clinical trial supply and commercial pharmaceutical services company. Originally a Philadelphia-area retail pharmacy tracing to 1865 (acquired by Morris Cohen in 1931), the company has evolved over three generations into an integrated clinical trial supply partner serving pharmaceutical sponsors, biotechnology companies, and contract research organizations (CROs) across North America and Europe. The company rebranded from Myoderm to Myonex in September 2020 to reflect its expanded global scope. It operates nine owned facilities across the US (Horsham, PA headquarters; Newark, DE), UK (Leicester), Germany (Berlin), and France (Le Haillan, Reims clinical and commercial, Bailly-Romainvilliers), and reports serving 267+ pharma and biotech clients.

Myonex's core offerings span clinical packaging, labeling and distribution; drug and ancillary sourcing from 60+ countries; pharmacy services through its wholly-owned 50-state US compounding pharmacy SaveWay; bioservices including cryogenic storage down to -196°C for cell and gene therapies and ATMPs; and contract commercial packaging. The flagship proprietary platform, CTRx®, combines prescription card services, global pharmacy dispensing, and centralized local drug supply into a single integrated solution accessed through the myCTcentral® portal, with a US pharmacy network exceeding 70,000 locations. Underlying capabilities include GMP/GDP-certified facilities, QP release services for the EU/UK, NABP Drug Distributor Accreditation, Qualiopi-certified training, and Just-In-Time labeling supported by supply chain simulation tools.

Revenue is generated primarily through project-based, quote-priced contracts for clinical trial supply services and managed commercial packaging services, supplemented by transaction-based fees for CTRx® prescription processing and consulting engagements. The go-to-market is sales-led through enterprise field sales targeting pharma sponsors, biotechs, and CROs, reinforced by event participation (CPHI, CTS, OCT, GCSG) and direct consultation requests. Customer engagements are typically multi-year contracts with a dedicated expert Project Manager assigned across the full scope, and exclusive manufacturer partnerships (e.g., Adalvo) provide differentiated drug access. Customer mix spans enterprise pharma (e.g., Debiopharm, URGO, Genethon), biotech (Lytix Biopharma, Brenus Pharma), CROs (Lexitas, CRS-hVIVO), and nonprofits (Leukemia & Lymphoma Society).

Short descriptiontext

Myonex (formerly Myoderm) is a family-owned clinical trial supply and commercial pharmaceutical services company operating nine GMP/GDP facilities across the US, UK, Germany, and France. It serves 267+ pharma, biotech, and CRO clients with integrated drug sourcing, packaging, distribution, compounding pharmacy, bioservices, and its proprietary CTRx® patient supply platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersHorsham, United States
HQ citystring
Horsham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial supply, pharmaceutical packaging services, comparator drug sourcing, cold chain logistics, pharmacy dispensing services
Industry3 codes
PRIMARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYCRAOAHAD
Specialty Pharmacy & Biologics Distribution
SECONDARYHLAAAKAJ
Packaging, Labeling & Serialization Services (biologics/cold chain)
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Clinical Trial Supply Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Clinical Trial Supply Services
TypeProfessional Services
Description

Integrated clinical trial supply services including packaging, labeling, distribution, drug sourcing, pharmacy services, and bioservices. Revenue generated through project fees, service contracts, and per-transaction pricing for clinical trial sponsors and CROs.

myonex.com
2Commercial Pharmaceutical Packaging Services
TypeManaged Services
Description

Contract packaging and repackaging services for marketed pharmaceutical products including primary packaging (blistering and bottling), secondary packaging, serialization, and commercial storage for brand and generic drugs.

myonex.com
3Consulting Services
TypeProfessional Services
Description

Pharmacist consulting, supply chain optimization, and ultra-cold chain consulting services provided to pharma and biotech companies.

myonex.com
4CTRx® Solution
TypeTransaction Fee
Description

Prescription card services and global pharmacy dispensing generating fees based on prescription processing and local drug supply coordination for clinical trials.

myonex.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details1 tier
1Project-based pricing for clinical trial supply and commercial packaging services
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is quote-based and project-specific. The Sourcing Comparison Calculator allows sponsors to input study variables (treatment duration, patient enrollment, treatment unit cost, overage percentage) to compare estimated drug costs across Traditional/Bulk Sourcing, Site Sourcing, and CTRx® models. CTRx® eliminates overage buffer requirements, reducing total drug estimate costs.

myonex.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1SaveWay Compounding Pharmacy
Description

A Myonex company providing US 50-state compounding pharmacy services including sterile and non-sterile compounding, Direct to Patient dispensing for clinical trials

myonex.com
+2 more records
Core offering1 text field

Myoderm (operating as Myonex) provides integrated clinical trial supply and commercial pharmaceutical services for pharmaceutical, biotechnology, and CRO clients globally. Core offerings include comparator and ancillary drug sourcing, primary and secondary clinical packaging and labeling, global distribution, QP release services, bioservices (ATMP/cell & gene therapy storage and cryogenic biostorage down to -196°C), a fully-owned US 50-state compounding pharmacy (SaveWay), commercial packaging/serialization, and a proprietary CTRx® patient drug-supply solution combining prescription cards, global pharmacy dispensing, and centralized local drug supply.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Up to 65% cost saving compared to traditional central sourcing model (Debiopharm Phase III trial case study)
+6 more records
Product overview1 text field

Myonex is an integrated clinical trial supply and commercial pharmaceutical services company offering a comprehensive suite of solutions. The core offerings include CTRx® (a prescription card, pharmacy dispensing, and local drug supply platform), Clinical Packaging/Labeling/Distribution, Drug & Ancillary Sourcing, Pharmacy Services (via SaveWay Compounding Pharmacy), Bioservices (biostorage and ATMP supply chain), and Commercial Packaging. These services are supplemented by Consulting Services covering pharmacist consulting, supply chain optimization, and ultra-cold chain consulting. The myCTcentral® portal provides the technology interface for CTRx, while the Sourcing Comparison Calculator helps sponsors evaluate sourcing models. The company operates from facilities in the US, UK, Germany, and France.

Product and service1 record
1CTRx®
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-24
Description

The Leukemia & Lymphoma Society selected Myonex as its preferred partner to support patients in the LLS-sponsored Beat AML® Master Clinical Trial through CTRx® solution. Myonex manages medication support program ensuring uninterrupted access to commercial medications and comprehensive patient financial assistance. This partnership underscores Myonex's ability to respond to critical patient needs and foster mission-aligned partnerships supporting blood cancer research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-30
Description

Adalvo, a global B2B pharmaceutical company and one of Europe's leading generic and biosimilar suppliers, expanded its exclusive partnership with Myonex as the exclusive provider of Adalvo products for clinical trial use globally. Both parties expanded the agreement to include multiple new assets for global markets. Myonex helps pharmaceutical companies, biotechs, and CROs adopt generic and biosimilar medicines in clinical trials, reducing costs and ensuring adequate, timely supply. Adalvo has commercial partnerships in more than 130 countries and over 140 commercial partners globally.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Myonex designed and executes a hybrid local and central sourcing and labeling strategy for Debiopharm's Phase III clinical trial (Debio 4126-301) involving 70 investigational sites in 20 countries. The collaboration includes Just-In-Time labeling in EU, CTRx® local sourcing in 6 countries (Spain, France, UK, Brazil, Israel, USA), and myCTcentral® portal implementation. Projected up to 65% cost saving compared to traditional central sourcing model.

4Strategic Depot Network Partners
Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Myonex maintains a strategic partner depot network spanning Europe, North America, Latin America (LATAM), Asia Pacific (APAC), Middle East, and Africa to complement its own owned facilities for clinical distribution. Also leverages specialized and qualified 3PLs for ultra-cold logistics under Myonex expert supervision, trained in ADR (road transport) and IATA (air transport) regulations.

myonex.com
5Home Healthcare Providers (HHPs)
Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Home Healthcare Providers serve as distribution partners for Direct-to-Patient (DtP) clinical trial medication delivery in decentralized clinical trials. Myonex coordinates with HHPs for temperature-controlled distribution and logistics, patient sample collection, and unused drug returns as part of its DCT support services.

myonex.com
6Data Privacy Framework Certifying Bodies
Strategic tierSupportingTypeOthers
Description

Myonex is committed to EU-U.S. Data Privacy Framework, UK Extension to EU-U.S. DPF, and Swiss-U.S. Data Privacy Framework. FTC has jurisdiction over Myonex's compliance with these frameworks. This commitment ensures lawful data transfers from EU, UK, and Switzerland to the US.

myonex.com
Recent move13 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Marken is a global clinical trial supply chain and logistics provider offering direct-to-patient services, comparator sourcing, and biopharma cold chain logistics. Owned by UPS Healthcare, it competes directly with Myonex's clinical distribution and bioservices lines.

TypeDirect peer
Description

Biocair is a specialist global courier for clinical trial shipments and biopharmaceutical logistics with deep cold chain expertise including cryogenic and ultra-cold transport. Comparable to Myonex's bioservices and clinical distribution operations for cell/gene therapy and ATMP trials.

TypeDirect peer
Description

Clinigen is the closest direct peer, specializing in clinical trial supply, comparator sourcing, and managed access programs for pharma and biotech sponsors globally. Like Myonex, it offers integrated clinical supply solutions targeting the same sponsor and CRO buyer base.

TypeBroad incumbent
Description

DHL Supply Chain operates a global Life Sciences and Healthcare division with GMP-certified warehousing, clinical trial distribution, and cold chain capabilities. Broader incumbent with significant overlap in clinical distribution and comparator drug logistics.

TypeBroad incumbent
Description

Eurofins provides bioanalytical, central lab, and clinical trial support services globally through its pharma services division. A broader life sciences services incumbent that overlaps with Myonex's bioservices and clinical testing adjacencies.

TypeBroad incumbent
Description

Thermo Fisher, through PPD, provides end-to-end clinical trial services including clinical supply, packaging, and comparator sourcing as part of a broader CRO and life sciences tools portfolio. Represents the vertically integrated mega-vendor threat in clinical supply.

7Recipharm
TypeBroad incumbent
Description

Recipharm is a European-headquartered CDMO offering pharmaceutical development, clinical supply, and commercial manufacturing services. Comparable to Myonex in the European clinical packaging and supply space, particularly relevant for the German, French, and UK markets where Myonex operates.

TypeDirect peer
Description

Sharp Packaging Services provides commercial and clinical pharmaceutical packaging, serialization, and labeling services from GMP facilities globally. Directly comparable to Myonex's Reimbursement commercial packaging and Reims-based packaging operations.

TypeBroad incumbent
Description

Catalent is a large global CDMO offering clinical supply services, primary packaging, and comparator sourcing alongside its broader drug development and biologics manufacturing portfolio. A broader incumbent with overlapping clinical supply capabilities but operating at much larger scale.

TypeDirect peer
Description

PCI Pharma Services is a leading CDMO specializing in clinical and commercial packaging, labeling, serialization, and global drug supply. Direct competitor in Myonex's clinical packaging, labeling, and commercial packaging service lines with comparable GMP/GDP infrastructure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Myoderm

Clinical Trial Supply Servicesmyonex.com

Myonex (formerly Myoderm) is a family-owned clinical trial supply and commercial pharmaceutical services company operating nine GMP/GDP facilities across the US, UK, Germany, and France. It serves 267+ pharma, biotech, and CRO clients with integrated drug sourcing, packaging, distribution, compounding pharmacy, bioservices, and its proprietary CTRx® patient supply platform.

What Myoderm does

Myoderm, operating globally as Myonex, is a family-owned clinical trial supply and commercial pharmaceutical services company. Originally a Philadelphia-area retail pharmacy tracing to 1865 (acquired by Morris Cohen in 1931), the company has evolved over three generations into an integrated clinical trial supply partner serving pharmaceutical sponsors, biotechnology companies, and contract research organizations (CROs) across North America and Europe. The company rebranded from Myoderm to Myonex in September 2020 to reflect its expanded global scope. It operates nine owned facilities across the US (Horsham, PA headquarters; Newark, DE), UK (Leicester), Germany (Berlin), and France (Le Haillan, Reims clinical and commercial, Bailly-Romainvilliers), and reports serving 267+ pharma and biotech clients.

Myonex's core offerings span clinical packaging, labeling and distribution; drug and ancillary sourcing from 60+ countries; pharmacy services through its wholly-owned 50-state US compounding pharmacy SaveWay; bioservices including cryogenic storage down to -196°C for cell and gene therapies and ATMPs; and contract commercial packaging. The flagship proprietary platform, CTRx®, combines prescription card services, global pharmacy dispensing, and centralized local drug supply into a single integrated solution accessed through the myCTcentral® portal, with a US pharmacy network exceeding 70,000 locations. Underlying capabilities include GMP/GDP-certified facilities, QP release services for the EU/UK, NABP Drug Distributor Accreditation, Qualiopi-certified training, and Just-In-Time labeling supported by supply chain simulation tools.

Revenue is generated primarily through project-based, quote-priced contracts for clinical trial supply services and managed commercial packaging services, supplemented by transaction-based fees for CTRx® prescription processing and consulting engagements. The go-to-market is sales-led through enterprise field sales targeting pharma sponsors, biotechs, and CROs, reinforced by event participation (CPHI, CTS, OCT, GCSG) and direct consultation requests. Customer engagements are typically multi-year contracts with a dedicated expert Project Manager assigned across the full scope, and exclusive manufacturer partnerships (e.g., Adalvo) provide differentiated drug access. Customer mix spans enterprise pharma (e.g., Debiopharm, URGO, Genethon), biotech (Lytix Biopharma, Brenus Pharma), CROs (Lexitas, CRS-hVIVO), and nonprofits (Leukemia & Lymphoma Society).

Myoderm firmographics

Firmographics
Name
Myoderm
Legal name
Myonex, LLC
Website
https://myonex.com
Company type
Private
Founded year
1931
Operating status
Operating
Headcount range
251–500 employees
Short description
Myonex (formerly Myoderm) is a family-owned clinical trial supply and commercial pharmaceutical services company operating nine GMP/GDP facilities across the US, UK, Germany, and France. It serves 267+ pharma, biotech, and CRO clients with integrated drug sourcing, packaging, distribution, compounding pharmacy, bioservices, and its proprietary CTRx® patient supply platform.
Ownership category
akta.pro rank

Myoderm industry classification

Industry
Product category
Clinical Trial Supply Services
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYCRAOAHAD
Specialty Pharmacy & Biologics Distribution
SECONDARYHLAAAKAJ
Packaging, Labeling & Serialization Services (biologics/cold chain)

Keywords

  • Clinical trial supply
  • Pharmaceutical packaging services
  • Comparator drug sourcing
  • Cold chain logistics
  • Pharmacy dispensing services

Where Myoderm is headquartered

Location

Headquarters

HQ city
Horsham
HQ country
United States
HQ region
North America

Offices7 records

Markets served

Myoderm business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Clinical Trial Supply Services: Integrated clinical trial supply services including packaging, labeling, distribution, drug sourcing, pharmacy services, and bioservices. Revenue generated through project fees, service contracts, and per-transaction pricing for clinical trial sponsors and CROs.
  2. Commercial Pharmaceutical Packaging Services: Contract packaging and repackaging services for marketed pharmaceutical products including primary packaging (blistering and bottling), secondary packaging, serialization, and commercial storage for brand and generic drugs.
  3. Consulting Services: Pharmacist consulting, supply chain optimization, and ultra-cold chain consulting services provided to pharma and biotech companies.
  4. CTRx® Solution: Prescription card services and global pharmacy dispensing generating fees based on prescription processing and local drug supply coordination for clinical trials.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProject-based pricing for clinical trial supply and commercial packaging services

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Myoderm product offering

Product offering

Core offering

Myoderm (operating as Myonex) provides integrated clinical trial supply and commercial pharmaceutical services for pharmaceutical, biotechnology, and CRO clients globally. Core offerings include comparator and ancillary drug sourcing, primary and secondary clinical packaging and labeling, global distribution, QP release services, bioservices (ATMP/cell & gene therapy storage and cryogenic biostorage down to -196°C), a fully-owned US 50-state compounding pharmacy (SaveWay), commercial packaging/serialization, and a proprietary CTRx® patient drug-supply solution combining prescription cards, global pharmacy dispensing, and centralized local drug supply.

Product overview

Myonex is an integrated clinical trial supply and commercial pharmaceutical services company offering a comprehensive suite of solutions. The core offerings include CTRx® (a prescription card, pharmacy dispensing, and local drug supply platform), Clinical Packaging/Labeling/Distribution, Drug & Ancillary Sourcing, Pharmacy Services (via SaveWay Compounding Pharmacy), Bioservices (biostorage and ATMP supply chain), and Commercial Packaging. These services are supplemented by Consulting Services covering pharmacist consulting, supply chain optimization, and ultra-cold chain consulting. The myCTcentral® portal provides the technology interface for CTRx, while the Sourcing Comparison Calculator helps sponsors evaluate sourcing models. The company operates from facilities in the US, UK, Germany, and France.

Differentiator

Problem solved

Functional benefit

Brands

  • SaveWay Compounding Pharmacy: A Myonex company providing US 50-state compounding pharmacy services including sterile and non-sterile compounding, Direct to Patient dispensing for clinical trials
  • CTRx
  • myCTcentral

Products and services

  • CTRx®

Quantifiable outcome

  • Up to 65% cost saving compared to traditional central sourcing model (Debiopharm Phase III trial case study)
  • +6 more outcomes

Companies that use Myoderm

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles1 record

Myoderm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Myoderm partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and supporting.

  • The Leukemia & Lymphoma Society (LLS)coreStrategic or Co-development Partner · 24 June 2025The Leukemia & Lymphoma Society selected Myonex as its preferred partner to support patients in the LLS-sponsored Beat AML® Master Clinical Trial through CTRx® solution. Myonex manages medication support program ensuring uninterrupted access to commercial medications and comprehensive patient financial assistance. This partnership underscores Myonex's ability to respond to critical patient needs and foster mission-aligned partnerships supporting blood cancer research.
  • AdalvocoreStrategic or Co-development Partner · 30 October 2024Adalvo, a global B2B pharmaceutical company and one of Europe's leading generic and biosimilar suppliers, expanded its exclusive partnership with Myonex as the exclusive provider of Adalvo products for clinical trial use globally. Both parties expanded the agreement to include multiple new assets for global markets. Myonex helps pharmaceutical companies, biotechs, and CROs adopt generic and biosimilar medicines in clinical trials, reducing costs and ensuring adequate, timely supply. Adalvo has commercial partnerships in more than 130 countries and over 140 commercial partners globally.
  • DebiopharmcoreStrategic or Co-development PartnerMyonex designed and executes a hybrid local and central sourcing and labeling strategy for Debiopharm's Phase III clinical trial (Debio 4126-301) involving 70 investigational sites in 20 countries. The collaboration includes Just-In-Time labeling in EU, CTRx® local sourcing in 6 countries (Spain, France, UK, Brazil, Israel, USA), and myCTcentral® portal implementation. Projected up to 65% cost saving compared to traditional central sourcing model.
  • Strategic Depot Network PartnerssupportingChannel Partner/ Reseller/ DistributorMyonex maintains a strategic partner depot network spanning Europe, North America, Latin America (LATAM), Asia Pacific (APAC), Middle East, and Africa to complement its own owned facilities for clinical distribution. Also leverages specialized and qualified 3PLs for ultra-cold logistics under Myonex expert supervision, trained in ADR (road transport) and IATA (air transport) regulations.
  • Home Healthcare Providers (HHPs)supportingChannel Partner/ Reseller/ DistributorHome Healthcare Providers serve as distribution partners for Direct-to-Patient (DtP) clinical trial medication delivery in decentralized clinical trials. Myonex coordinates with HHPs for temperature-controlled distribution and logistics, patient sample collection, and unused drug returns as part of its DCT support services.
  • Data Privacy Framework Certifying BodiessupportingOthersMyonex is committed to EU-U.S. Data Privacy Framework, UK Extension to EU-U.S. DPF, and Swiss-U.S. Data Privacy Framework. FTC has jurisdiction over Myonex's compliance with these frameworks. This commitment ensures lawful data transfers from EU, UK, and Switzerland to the US.

Scale indicators11 records

Recent moves13 records

Expansion highlights8 records

Myoderm competitors and assessment

Company assessment

Direct peers

  • Marken (UPS Healthcare): Marken is a global clinical trial supply chain and logistics provider offering direct-to-patient services, comparator sourcing, and biopharma cold chain logistics. Owned by UPS Healthcare, it competes directly with Myonex's clinical distribution and bioservices lines.
  • Biocair: Biocair is a specialist global courier for clinical trial shipments and biopharmaceutical logistics with deep cold chain expertise including cryogenic and ultra-cold transport. Comparable to Myonex's bioservices and clinical distribution operations for cell/gene therapy and ATMP trials.
  • Clinigen Group: Clinigen is the closest direct peer, specializing in clinical trial supply, comparator sourcing, and managed access programs for pharma and biotech sponsors globally. Like Myonex, it offers integrated clinical supply solutions targeting the same sponsor and CRO buyer base.
  • Sharp Packaging Services (Stericycle): Sharp Packaging Services provides commercial and clinical pharmaceutical packaging, serialization, and labeling services from GMP facilities globally. Directly comparable to Myonex's Reimbursement commercial packaging and Reims-based packaging operations.
  • PCI Pharma Services: PCI Pharma Services is a leading CDMO specializing in clinical and commercial packaging, labeling, serialization, and global drug supply. Direct competitor in Myonex's clinical packaging, labeling, and commercial packaging service lines with comparable GMP/GDP infrastructure.

Broad incumbents

  • DHL Supply Chain (Life Sciences & Healthcare): DHL Supply Chain operates a global Life Sciences and Healthcare division with GMP-certified warehousing, clinical trial distribution, and cold chain capabilities. Broader incumbent with significant overlap in clinical distribution and comparator drug logistics.
  • Eurofins Scientific: Eurofins provides bioanalytical, central lab, and clinical trial support services globally through its pharma services division. A broader life sciences services incumbent that overlaps with Myonex's bioservices and clinical testing adjacencies.
  • Thermo Fisher Scientific (PPD Clinical Research): Thermo Fisher, through PPD, provides end-to-end clinical trial services including clinical supply, packaging, and comparator sourcing as part of a broader CRO and life sciences tools portfolio. Represents the vertically integrated mega-vendor threat in clinical supply.
  • Recipharm: Recipharm is a European-headquartered CDMO offering pharmaceutical development, clinical supply, and commercial manufacturing services. Comparable to Myonex in the European clinical packaging and supply space, particularly relevant for the German, French, and UK markets where Myonex operates.
  • Catalent: Catalent is a large global CDMO offering clinical supply services, primary packaging, and comparator sourcing alongside its broader drug development and biologics manufacturing portfolio. A broader incumbent with overlapping clinical supply capabilities but operating at much larger scale.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

Myoderm social profiles

Digital presence

Myoderm compliance and trust

Trust signal

Compliance10 records

Myoderm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Myoderm leadership team

Management profile

Number of profiles

Profiles8 records

Myoderm subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Myoderm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Myoderm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Myoderm

What does Myoderm do?

Myoderm (operating as Myonex) provides integrated clinical trial supply and commercial pharmaceutical services for pharmaceutical, biotechnology, and CRO clients globally. Core offerings include comparator and ancillary drug sourcing, primary and secondary clinical packaging and labeling, global distribution, QP release services, bioservices (ATMP/cell & gene therapy storage and cryogenic biostorage down to -196°C), a fully-owned US 50-state compounding pharmacy (SaveWay), commercial packaging/serialization, and a proprietary CTRx® patient drug-supply solution combining prescription cards, global pharmacy dispensing, and centralized local drug supply.

Is Myoderm a public or private company?

Myoderm is a private company. It is classified as family owned and is currently operating.

When was Myoderm founded?

Myoderm was founded in 1931. It employs 251 to 500 people.

Where is Myoderm based?

Myoderm is headquartered in Horsham, United States, in the North America region.

How does Myoderm make money?

Four revenue lines are on record. Clinical Trial Supply Services are the primary driver. The others are commercial Pharmaceutical Packaging Services, consulting Services and CTRx® Solution.

Who are Myoderm's main competitors?

Direct peers on record are Marken (UPS Healthcare), Biocair, Clinigen Group, Sharp Packaging Services (Stericycle) and PCI Pharma Services. Broad incumbents are DHL Supply Chain (Life Sciences & Healthcare), Eurofins Scientific, Thermo Fisher Scientific (PPD Clinical Research), Recipharm and Catalent.

Does Myoderm have an API?

No public API is recorded for Myoderm.

What industry is Myoderm in?

Myoderm's product category is Clinical Trial Supply Services. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of CRAOAHAD, Specialty Pharmacy & Biologics Distribution. Its NAICS code is 325412 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals